| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |